These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 11596994

  • 1. Identification of the accumulated ganglioside.
    Svennerholm L.
    Adv Genet; 2001; 44():33-41. PubMed ID: 11596994
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of some minor gangliosides in Tay-Sachs brains.
    Yu RK, Itoh T, Yohe HC, Macala LJ.
    Brain Res; 1983 Sep 19; 275(1):47-52. PubMed ID: 6414648
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G, Wendeler M, Sandhoff K.
    Glycobiology; 2005 Dec 19; 15(12):1302-11. PubMed ID: 16079415
    [Abstract] [Full Text] [Related]

  • 4. Molecular genetics of the beta-hexosaminidase isoenzymes: an introduction.
    Kolodny EH.
    Adv Genet; 2001 Dec 19; 44():101-26. PubMed ID: 11596976
    [No Abstract] [Full Text] [Related]

  • 5. Brain gangliosides: an improved simple method for their extraction and identification.
    Randell JA, Pennock CA.
    J Chromatogr; 1980 Jul 18; 195(2):257-64. PubMed ID: 6773970
    [Abstract] [Full Text] [Related]

  • 6. Ganglioside-composition of brain in Tay-Sachs disease: increased amounts of GD2 and N-acetyl-beta-D-galactosaminyl GD1a ganglioside.
    Iwamori M, Nagai Y.
    J Neurochem; 1979 Mar 18; 32(3):767-77. PubMed ID: 430057
    [No Abstract] [Full Text] [Related]

  • 7. The GM2-gangliosidoses and the elucidation of the beta-hexosaminidase system.
    Sandhoff K.
    Adv Genet; 2001 Mar 18; 44():67-91. PubMed ID: 11597000
    [No Abstract] [Full Text] [Related]

  • 8. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
    Rosengren B, Månsson JE, Svennerholm L.
    J Neurochem; 1987 Sep 18; 49(3):834-40. PubMed ID: 3612128
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A, Holding J, Carey WF.
    Clin Chim Acta; 1982 Apr 23; 120(3):331-40. PubMed ID: 6210469
    [Abstract] [Full Text] [Related]

  • 10. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
    Hoffman LM, Brooks SE, Stein MR, Adachi M, Schneck L.
    Metab Brain Dis; 1989 Jun 23; 4(2):87-93. PubMed ID: 2547146
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ganglioside accumulation in cultured skin fibroblasts from gangliosidosis patients.
    Pullarkat RK, Reha H, Beratis NG.
    Biochem Biophys Res Commun; 1980 Jan 15; 92(1):149-54. PubMed ID: 7356448
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M, Inui K, Hirabayashi Y, Tsukamoto H, Nishimoto J, Midorikawa M, Okada S, Yabuuchi H.
    J Inherit Metab Dis; 1989 Jan 15; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract] [Full Text] [Related]

  • 14. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM, Brooks SE, Amsterdam D, Oropello J, Schneck L.
    J Neurosci Res; 1980 Jan 15; 5(5):413-7. PubMed ID: 7441795
    [Abstract] [Full Text] [Related]

  • 15. Discovery of beta-hexosaminidase A deficiency in Tay-Sachs disease.
    Okada S, O'Brien JS.
    Adv Genet; 2001 Jan 15; 44():61-6. PubMed ID: 11596999
    [No Abstract] [Full Text] [Related]

  • 16. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL.
    Nat Genet; 1995 Oct 15; 11(2):170-6. PubMed ID: 7550345
    [Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain.
    Itoh T, Li YT, Li SC, Yu RK.
    J Biol Chem; 1981 Jan 10; 256(1):165-9. PubMed ID: 7451432
    [Abstract] [Full Text] [Related]

  • 18. A new variant of type-AB GM2-gangliosidosis.
    Li SC, Hirabayashi Y, Li YT.
    Biochem Biophys Res Commun; 1981 Jul 30; 101(2):479-85. PubMed ID: 7306091
    [No Abstract] [Full Text] [Related]

  • 19. Extraction and purification of gangliosides from plasma and fibroblasts before analysis by thin layer chromatography.
    Leenders RG, de Jong JG, Wevers RA.
    Ann Clin Biochem; 1995 Jan 30; 32 ( Pt 1)():68-73. PubMed ID: 7762953
    [Abstract] [Full Text] [Related]

  • 20. CHROMATOGRAPHIC STUDIES OF NORMAL AND TAY-SACHS GANGLIOSIDES (PEPTIDE-STRANDIN).
    SAIFER A, ROBIN M, VOLK BW.
    J Neurochem; 1963 Aug 30; 10():577-86. PubMed ID: 14062003
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.